DHR

Danaher Corporation

Technology
176.11 -3.76 -2.09% Market Closed
2026-06-02 • USD

Key Metrics

Market Cap 124.65B
EV —
Shares Out 707.77M
Revenue (ttm) 24.78B
Net Income 3.69B
Beta —
P/E 33.79
Forward P/E —
EPS (ttm) $5.18
P/S 5.03
P/B 2.35
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA 4.47%
ROE 7.01%
ROIC 5.64%
Gross Margin 58.94%
Oper. Margin 19.21%
Profit Margin 14.89%
Debt/Eq 0.35
LT Debt/Eq 24.91%
Quick Ratio —
Current Ratio 1.87
Book/sh 74.8
Cash/sh —
Div Yield —
Div TTM —
Payout Ratio —
SMA20 2.56%
SMA50 -2.87%
SMA200 -14.42%
Volume 2,914,086
Avg Volume 4.54M
Rel Volume —
Perf Week -3.59%
Perf Month 0.85%
Perf Quarter -12.82%
Perf Half Y -22.16%
Perf YTD -23.07%
Perf Year -8.35%
Perf 3Y -14.77%
Perf 5Y -17.99%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Danaher Corporation is a global science and technology company with leading positions in the life sciences and diagnostics sectors. The Company operates through three primary segments: Biotechnology, Life Sciences, and Diagnostics. Danaher serves customers across diverse end-markets including pharmaceuticals, biotechnology, medical devices, healthcare diagnostics, environmental solutions, and applied end-markets. The Company's portfolio includes research tools, diagnostic systems, and specialty products used for drug discovery, clinical diagnostics, and patient monitoring. Danaher operates globally with a presence in North America, Western Europe, and high-growth markets, supporting customers in over 190 countries with approximately 24.6 billion in sales in 2025.

Name
Danaher Corporation
Industry
Technology
CEO
Rainer M. Blair · President and Chief Executive Officer
Employees
—
IPO Date
2020-02-04
Phone
(202) 828-0850
Address
2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037-1701
Website
investors.danaher.com

Key Executives

Name Title FY Pay
Rainer M. Blair President and Chief Executive Officer $23.8M
Julie Sawyer Montgomery Executive Vice President $11.3M
Christopher P. Riley Executive Vice President $11.3M
Matthew R. McGrew Executive Vice President and Chief Financial Officer $8.0M
Jose-Carlos Gutierrez-Ramos Senior Vice President and Chief Science Officer $6.2M

Latest News